All funded medicines in New Zealand.
Hospital Medicines (HML)
About the Schedule
Rules of the Schedule
Hospital Medical Devices
Medicine funding and supply
Ask us to fund a medicine | Check changes to medicines | How do generics work?
Make an application
Medicine notices (includes supply issues)
Brand changes, discontinuations and more.
The funding process
What you need to know about medicines
Medicine supply management
Order condoms and nicotine replacement | About supply management
Hospital medical devices
PHARMAC contracts with device suppliers to ensure our hospitals can buy medical devices at fairer prices.
Download the latest hospital medical devices schedule
Medical devices we have contracted and the ones we're working on
Our role in hospital medical devices
Read and subscribe to our devices newsletter
Te Tiriti o Waitangi
Te Pātaka Whaioranga's Māori Responsiveness Strategy
The Māori health areas of focus
Programmes to support Māori health
Scholarships, awards and programmes
How we work with Whānau Ora
News and resources
Consultations and decisions
includes RFPs and tenders.
News and updates
Official Information Act
Our responses to OIA requests
Publications and resources
At a Glance: Pharmac in numbers
See the difference we made in 2020/21.
Our plan to deliver the best health outcomes for New Zealanders
The Pharmac Review
Our work to improve equity of access to medicines in New Zealand.
Pacific Responsiveness Strategy
What we do
Who we are
How we get expert advice
Advice we seek to make decisions
Working at Pharmac
Explore current vacancies
How to get in touch
These funding criteria are updated regularly in response to the need and availability of the medicines.
Access criteria for molnupiravir (Lagevrio), nirmatrelvir with ritonavir (Paxlovid), and remdesivir (Veklury)